Know Cancer

or
forgot password
  • cancer clinical trials in nashville, TN

  • Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
    Vanderbilt-Ingram Cancer Center at Franklin
    Nashville, Tennessee 37064
    Lung Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
    The Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma
    Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    MBCCOP - Meharry Medical College - Nashville
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Neurocognitive Impairment, Delirium, Esophageal Cancer, Head and Neck Cancer, Lung Cancer
    Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Lung Cancer
    AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Thyroid Cancer, Stage I Papillary Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IV Papillary Thyroid Cancer
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Prostate Cancer
    Safety Study of TAK-700 in Subjects With Prostate Cancer.
    Tennessee Oncology
    Nashville, Tennessee 37203
    Prostatic Neoplasms
    Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Recurrent Respiratory Papillomatosis
    SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Mucosal Melanoma, Acral/Lentiginous Melanoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Vanderbilt University

    Trial Locations
    Vanderbilt University
    Meharry Medical College
    Nashville Oncology Associates PC
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
    Vanderbilt Medical Center
    Nashville, Tennessee 37232-2765
    Rectal Cancer
    Neurobiology and Treatment of Reading Disability in NF-1
    Vanderbilt University, Vanderbilt University Institute of Imaging Science
    Nashville, Tennessee 37232-2310
    Neurofibromatosis Type 1, Reading Disabilities
    Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Veterans Affairs Medical Center - Nashville
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Colorectal Cancer, Precancerous Condition
    Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
    Vanderbilt-Ingram Cancer Center - Cool Springs

    Trial Locations
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Breast Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Hepatic Veno-Occlusive Disease
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    Vanderbilt-Ingram Cancer Ctr
    Nashville, Tennessee 37232
    High Risk Stage III Melanoma
    Improving Outcomes Assessment in Chronic GVHD
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Chronic Graft Versus Host Disease
    CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Prostate Cancer, Prostatic Cancer, Prostatic Neoplasms, Prostate Neoplasms, Cancer of the Prostate
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Bladder Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Tennessee Oncology, PLLC at Sarah Cannon Cancer Center
    Leukemia
    Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
    Vanderbilt-Ingram Cancer Center at Franklin

    Trial Locations
    Vanderbilt-Ingram Cancer Center at Franklin
    Vanderbilt-Ingram Cancer Center, One Hundred Oaks
    Breast Cancer
    Energy Balance Interventions for Colorectal Cancer Prevention
    Vanderbilt-Ingram Cancer Center at Franklin
    Nashville, Tennessee 37064
    Colorectal Cancer, Obesity
    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
    MBCCOP - Meharry Medical College - Nashville
    Nashville, Tennessee 37208-3599
    Breast Cancer, Fatigue, Sleep Disorders
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #076
    Nashville, Tennessee 37203
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
    The Sarah Cannon Cancer Center
    Nashville, Tennessee 37203
    Refractory Solid Tumors, Lymphoma
    Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Colorectal Cancer, Hereditary Nonpolyposis Colorectal Cancer, Precancerous Condition
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Meharry Medical College

    Trial Locations
    Meharry Medical College
    Nashville Oncology Associates PC
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Thyroid Cancer